Verano Holdings (VRNO) Cost of Revenue (2021 - 2026)

Verano Holdings (VRNO) reported Cost of Revenue of $109.2 million for Q1 2026, down 0.93% year-over-year from $110.2 million in Q1 2025, and up 8.21% quarter-over-quarter from $100.9 million in Q4 2025.

Verano Holdings (VRNO) Cost of Revenue (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Cost of Revenue data on file, last reported at $109.2 million in Q1 2026.

  • Cost of Revenue for Q1 2026 came in at $109.2 million, down 0.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $407.0 million (down 6.77% YoY), and the FY2025 annual result was $408.0 million, down 6.13% from the prior year.
  • Cost of Revenue advanced to $109.2 million in Q1 2026 per VRNO's latest filing, from $100.9 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $125.5 million in Q2 2022 and troughed at $1.1 million in Q1 2022.
  • A 5-year average of $104.1 million and a median of $108.3 million in 2024 frame the typical range for Cost of Revenue.
  • The sharpest annual moves came in 2023 and 2025: Cost of Revenue jumped 11104.85% in 2023, then declined 17.36% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $122.6 million in 2022, then dropped by 2.46% to $119.6 million in 2023, then declined by 7.45% to $110.7 million in 2024, then declined by 8.81% to $100.9 million in 2025, then gained by 8.21% to $109.2 million in 2026.
  • Business Quant data shows VRNO's Cost of Revenue at $109.2 million in Q1 2026, $100.9 million in Q4 2025, and $107.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 696.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 641.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 133.40 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 34.44 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 13.80 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 586.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 155.56 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 52.68 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 222.00 Mn
10 Verano Holdings - - 98.98 Mn 109.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 109.20 Mn
Mar 31, 2026 109.20 Mn
Dec 31, 2025 100.92 Mn
Dec 31, 2025 100.92 Mn
Sep 30, 2025 107.57 Mn
Sep 30, 2025 107.57 Mn
Jun 30, 2025 89.29 Mn
Jun 30, 2025 89.29 Mn
Mar 31, 2025 110.23 Mn
Mar 31, 2025 110.23 Mn
Dec 31, 2024 110.67 Mn
Dec 31, 2024 110.67 Mn
Sep 30, 2024 107.59 Mn
Sep 30, 2024 107.59 Mn
Jun 30, 2024 108.05 Mn
Jun 30, 2024 108.05 Mn
Mar 31, 2024 108.35 Mn
Mar 31, 2024 108.35 Mn
Dec 31, 2023 119.58 Mn
Dec 31, 2023 119.58 Mn